Hypercalcemia and bone metastases in breast cancer.
Warrell
R P
RP
Memorial Sloan-Kettering Cancer Center, New York, New York.
D019386:Alendronate; D001859:Bone Neoplasms / Q000556:secondary*; D001943:Breast Neoplasms / Q000473:pathology*; D004002:Clodronic Acid / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D012968:Etidronic Acid / Q000627:therapeutic use; D006934:Hypercalcemia / Q000188:drug therapy / Q000209:etiology*; D009363:Neoplasm Proteins / Q000502:physiology; D000077268:Pamidronate; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins / Q000502:physiology; D015291:Transforming Growth Factors / Q000502:physiology
D004164:Diphosphonates; D009363:Neoplasm Proteins; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D004002:Clodronic Acid; D015291:Transforming Growth Factors; D012968:Etidronic Acid; D000077268:Pamidronate; D019386:Alendronate